Skip to main content
. 2022 Jun 11;94(10):4599–4610. doi: 10.1002/jmv.27907

Figure 2.

Figure 2

Schematic diagram shows the contribution of bovine‐derived biotherapeutics to human health. Humans can be supplied with hyperimmunized milk from transchromosomic (Tc) bovines, which can be utilized to make dairy products with protective antibodies. Also, Tc bovine vaccination triggers the adaptive immune response in cattle, allowing Tc bovine B cells to release human polyclonal antibodies that target a wide range of epitopes, reducing the risk of viral infections gaining mutational resistance.